Literature DB >> 25340724

Clozapine augmentation with amisulpride.

Stefano Porcelli1, Alessandro Serretti1, Oriana Bianchini2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25340724      PMCID: PMC4214877          DOI: 10.1503/jpn.140094

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  13 in total

1.  Augmentation of clozapine with a second antipsychotic - a meta-analysis.

Authors:  D M Taylor; L Smith; S H Gee; J Nielsen
Journal:  Acta Psychiatr Scand       Date:  2011-11-12       Impact factor: 6.392

2.  Drugs and valvular heart disease.

Authors:  Bryan L Roth
Journal:  N Engl J Med       Date:  2007-01-04       Impact factor: 91.245

Review 3.  Amisulpride: a review of its use in the management of schizophrenia.

Authors:  Kate McKeage; Greg L Plosker
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Authors:  M Chakos; J Lieberman; E Hoffman; D Bradford; B Sheitman
Journal:  Am J Psychiatry       Date:  2001-04       Impact factor: 18.112

5.  Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment.

Authors:  Ina Giegling; Antonio Drago; Martin Schäfer; Hans-Jürgen Möller; Dan Rujescu; Alessandro Serretti
Journal:  J Psychiatr Res       Date:  2009-12-03       Impact factor: 4.791

6.  Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.

Authors:  H-J Assion; H Reinbold; S Lemanski; M Basilowski; G Juckel
Journal:  Pharmacopsychiatry       Date:  2008-01       Impact factor: 5.788

Review 7.  Treatment-resistant schizophrenic patients.

Authors:  J M Kane
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

8.  Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.

Authors:  J Munro; P Matthiasson; S Osborne; M Travis; S Purcell; A M Cobb; M Launer; M D Beer; R Kerwin
Journal:  Acta Psychiatr Scand       Date:  2004-10       Impact factor: 6.392

9.  Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.

Authors:  Atheir I Abbas; Peter B Hedlund; Xi-Ping Huang; Thuy B Tran; Herbert Y Meltzer; Bryan L Roth
Journal:  Psychopharmacology (Berl)       Date:  2009-04-01       Impact factor: 4.530

Review 10.  Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.

Authors:  Hans-Jürgen Möller
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-10       Impact factor: 5.067

View more
  1 in total

1.  Amisulpride augmentation for clozapine-refractory positive symptoms: additional benefit in reducing hypersialorrhea.

Authors:  Fabiani Bogorni; Frederico Fernandes Moreira; Eduardo Mylius Pimentel; Géder Evandro Motta Grohs; Alexandre Paim Diaz
Journal:  Case Rep Psychiatry       Date:  2015-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.